These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26806387)

  • 41. MicroRNA Profiling in Aqueous Humor of Individual Human Eyes by Next-Generation Sequencing.
    Wecker T; Hoffmeier K; Plötner A; Grüning BA; Horres R; Backofen R; Reinhard T; Schlunck G
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1706-13. PubMed ID: 27064390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential Expression of microRNA in Cerebrospinal Fluid as a Potential Novel Biomarker for Alzheimer's Disease.
    van Harten AC; Mulders J; Scheltens P; van der Flier WM; Oudejans CB
    J Alzheimers Dis; 2015; 47(1):243-52. PubMed ID: 26402772
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasminogen activator inhibitor-1 as an early potential diagnostic marker for Alzheimer's disease.
    Oh J; Lee HJ; Song JH; Park SI; Kim H
    Exp Gerontol; 2014 Dec; 60():87-91. PubMed ID: 25304332
    [TBL] [Abstract][Full Text] [Related]  

  • 44. miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer's disease and other types of dementia - an exploratory study.
    Sørensen SS; Nygaard AB; Christensen T
    Transl Neurodegener; 2016; 5():6. PubMed ID: 26981236
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of Micro-RNA Expression by qPCR on a Microfluidics Platform for Alzheimer's Disease Biomarker Discovery.
    Takousis P
    Methods Mol Biol; 2018; 1750():283-292. PubMed ID: 29512080
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma protein profiling of mild cognitive impairment and Alzheimer's disease across two independent cohorts.
    Muenchhoff J; Poljak A; Song F; Raftery M; Brodaty H; Duncan M; McEvoy M; Attia J; Schofield PW; Sachdev PS
    J Alzheimers Dis; 2015; 43(4):1355-73. PubMed ID: 25159666
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis.
    Momen-Heravi F; Saha B; Kodys K; Catalano D; Satishchandran A; Szabo G
    J Transl Med; 2015 Aug; 13():261. PubMed ID: 26264599
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential expression of microRNAs in Alzheimer's disease brain, blood, and cerebrospinal fluid.
    Takousis P; Sadlon A; Schulz J; Wohlers I; Dobricic V; Middleton L; Lill CM; Perneczky R; Bertram L
    Alzheimers Dement; 2019 Nov; 15(11):1468-1477. PubMed ID: 31495604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating Biomarker Panels in Alzheimer's Disease.
    Zafari S; Backes C; Meese E; Keller A
    Gerontology; 2015; 61(6):497-503. PubMed ID: 25720553
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology.
    Burgos K; Malenica I; Metpally R; Courtright A; Rakela B; Beach T; Shill H; Adler C; Sabbagh M; Villa S; Tembe W; Craig D; Van Keuren-Jensen K
    PLoS One; 2014; 9(5):e94839. PubMed ID: 24797360
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alzheimer's disease: presence and role of microRNAs.
    Basavaraju M; de Lencastre A
    Biomol Concepts; 2016 Aug; 7(4):241-52. PubMed ID: 27505094
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Novel Plasma Based Biomarker of Alzheimer's Disease.
    Bradley-Whitman MA; Abner E; Lynn BC; Lovell MA
    J Alzheimers Dis; 2015; 47(3):761-71. PubMed ID: 26401710
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chromosomal DNA damage measured using the cytokinesis-block micronucleus cytome assay is significantly associated with cognitive impairment in South Australians.
    Lee SL; Thomas P; Hecker J; Faunt J; Fenech M
    Environ Mol Mutagen; 2015 Jan; 56(1):32-40. PubMed ID: 25099033
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PiB-PET Imaging-Based Serum Proteome Profiles Predict Mild Cognitive Impairment and Alzheimer's Disease.
    Kang S; Jeong H; Baek JH; Lee SJ; Han SH; Cho HJ; Kim H; Hong HS; Kim YH; Yi EC; Seo SW; Na DL; Hwang D; Mook-Jung I
    J Alzheimers Dis; 2016 Jul; 53(4):1563-76. PubMed ID: 27392853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells.
    Sanders KA; Benton MC; Lea RA; Maltby VE; Agland S; Griffin N; Scott RJ; Tajouri L; Lechner-Scott J
    Clin Epigenetics; 2016; 8(1):87. PubMed ID: 27570566
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Validation of AclarusDx™, a blood-based transcriptomic signature for the diagnosis of Alzheimer's disease.
    Fehlbaum-Beurdeley P; Sol O; Désiré L; Touchon J; Dantoine T; Vercelletto M; Gabelle A; Jarrige AC; Haddad R; Lemarié JC; Zhou W; Hampel H; Einstein R; Vellas B;
    J Alzheimers Dis; 2012; 32(1):169-81. PubMed ID: 22785402
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oxidative signature of cerebrospinal fluid from mild cognitive impairment and Alzheimer disease patients.
    Di Domenico F; Pupo G; Giraldo E; Badìa MC; Monllor P; Lloret A; Schininà ME; Giorgi A; Cini C; Tramutola A; Butterfield DA; Viña J; Perluigi M
    Free Radic Biol Med; 2016 Feb; 91():1-9. PubMed ID: 26675344
    [TBL] [Abstract][Full Text] [Related]  

  • 58. C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease.
    De Vos A; Jacobs D; Struyfs H; Fransen E; Andersson K; Portelius E; Andreasson U; De Surgeloose D; Hernalsteen D; Sleegers K; Robberecht C; Van Broeckhoven C; Zetterberg H; Blennow K; Engelborghs S; Vanmechelen E
    Alzheimers Dement; 2015 Dec; 11(12):1461-1469. PubMed ID: 26092348
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease.
    Ding H; Huang Z; Chen M; Wang C; Chen X; Chen J; Zhang J
    Parkinsonism Relat Disord; 2016 Jan; 22():68-73. PubMed ID: 26631952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.